Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma
==================================================================================================================================================================

* Ganesan Ramamoorthi
* Krithika Kodumudi
* Colin Snyder
* Payal Grover
* Hongtao Zhang
* Mark I Greene
* Amrita Basu
* Corey Gallen
* Doris Wiener
* Ricardo L B Costa
* Hyo S Han
* Gary Koski
* Brian J Czerniecki